期刊文献+

紫癜合剂对原发免疫性血小板减少症患者Treg/Th17细胞平衡的影响 被引量:3

Effects of Zidian Mixture on Treg/Th17 cell balance in patients with primary immune thrombocytopenia
下载PDF
导出
摘要 目的探讨紫癜合剂对原发免疫性血小板减少症(ITP)患者Treg、Th17细胞及其相关转录因子表达的影响。方法选取60例ITP患者,随机分为中药组和激素组,每组各30例。中药组患者予紫癜合剂口服治疗,激素组患者予强的松口服治疗,治疗周期为3个月。比较两组患者的外周血血小板计数、出血评分及生活质量评分;检测患者的血清中Treg、Th17细胞表达,比较两组患者的Treg/Th17比值;检测患者的RORγt mRNA、Foxp3 mRNA表达,比较两组患者的Foxp3/RORγt比值。结果①治疗后,两组患者的血小板计数较治疗前明显上升(P<0.05),出血评分及生活质量评分较治疗前明显降低(P<0.05),且中药组患者的出血评分、生活质量评分明显低于激素组(P<0.05)。②治疗后,中药组患者的Treg细胞表达及Treg/Th17比值较治疗前明显升高(P<0.05),激素组患者的Treg/Th17比值较治疗前升高(P<0.05),中药组患者的Treg细胞表达及Treg/Th17比值高于激素组(P<0.05)。③治疗后,中药组患者的Foxp3 mRNA表达及Foxp3/RORγt比值较治疗前明显上升(P<0.05),且中药组患者的Foxp3 mRNA表达及Foxp3/RORγt比值明显高于激素组(P<0.05)。结论紫癜合剂能有效提升ITP患者的血小板计数,改善出血症状及生活质量,调整体内Treg/Th17免疫失衡状态。 Objective To investigate the effects of Zidian Mixture on Treg and Th17 cells and expressions of related transcription factors in patients with primary immune thrombocytopenia(ITP).Methods Sixty patients with ITP were randomly divided into the Chinese medicine group and hormone group,30 cases in each group.The Chinese medicine group was orally treated with Zidian Mixture,while the hormone group was orally treated with prednisone,with a course of three months.The platelet count in peripheral blood,bleeding score and life quality score were compared between the two groups.The expressions of Treg and Th17 cells in serum were detected,and the Treg/Th17 ratio of the two groups was compared.The mRNA expressions of RORγt and Foxp3 were detected,and the Foxp3/RORγt ratio of the two groups was compared.Results①After treatment,the platelet count of the two groups was increased significantly compared with treatment before(P<0.05),and the bleeding score and life quality score were decreased significantly(P<0.05).The bleeding score and life quality score in the Chinese medicine group were obviously lower than those in the hormone group(P<0.05).②After treatment,the Treg cell expression and Treg/Th17 ratio in the Chinese medicine group were significantly increased compared with treatment before(P<0.05),and the Treg/Th17 ratio in the hormone group was also increased compared with treatment before(P<0.05).The Treg cell expression and Treg/Th17 ratio in the Chinese medicine group were higher than those in the hormone group(P<0.05).③After treatment,the expression of Foxp3 mRNA and Foxp3/RORγt ratio in the Chinese medicine group were significantly increased compared with treatment before(P<0.05),and the expression of Foxp3 mRNA and Foxp3/RORγt ratio in the Chinese medicine group were obviously higher than those in the hormone group(P<0.05).Conclusion Zidian Mixture can effectively increase platelet count,improve bleeding symptoms and quality of life,and adjust Treg/Th17 immune imbalance in patients with ITP.
作者 朱小勤 陈珮 邱仲川 黄中迪 赵琳 胡晓莹 瞿玮颖 陆颖佳 封舟 ZHU Xiaoqin;CHEN Pei;QIU Zhongchuan;HUANG Zhongdi;ZHAO Lin;HU Xiaoying;QU Weiying;LU Yingjia;FENG Zhou(Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200021,China)
出处 《上海中医药杂志》 2020年第S01期86-89,共4页 Shanghai Journal of Traditional Chinese Medicine
基金 上海市卫健委中医药科研专项项目(2016LP045) 上海市中医优势病种培育项目(zybz-2017006).
关键词 紫癜合剂 原发免疫性血小板减少症 TREG TH17 中医药疗法 Zidian Mixture primary immune thrombocytopenia Treg Th17 Chinese medical therapy
  • 相关文献

参考文献2

二级参考文献29

  • 1陈国佩,黄开艳.侧柏叶炮制的实验研究[J].中药材,1994,17(5):24-27. 被引量:11
  • 2ProvanD, StasiR, NewlandAC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia[J]. Blood,2010,115(2):168-186. 被引量:1
  • 3NeunertC, LimW, CrowtherM, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J]. Blood,2011,117(16):4190-4207. 被引量:1
  • 4British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy[J]. Br J Haematol,2003,120(4):574-596. doi:10.1046/j.1365-2141.2003.04131.x. 被引量:1
  • 5WeiY, JiXB, WangYW, et al. High-dose dexamethasone versus prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial[J]. Blood,2016,127(3):296-302. doi:10.1182/blood-2015-07-659656. 被引量:1
  • 6WangS, YangR, ZouP, et al. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia[J]. Int J Hematol,2012,96(2):222-228. doi:10.1007/s12185-012-1124-8. 被引量:1
  • 7BusselJB, ChengG, SalehMN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura[J]. N Engl J Med,2007,357(22):2237-2247. doi:10.1056/NEJMoa073275. 被引量:1
  • 8BusselJB, ProvanD, ShamsiT, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, doubleblind, placebo-controlled trial[J]. Lancet,2009,373(9664):641-648. doi:10.1016/S0140-6736(09)60402-5. 被引量:1
  • 9ChengG, SalehMN, MarcherC, et al. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study[J]. Lancet,2011,377(9763):393-402. doi:10.1016/S0140-6736(10)60959-2. 被引量:1
  • 10SalehMN, BusselJB, ChengG, et al. Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study[J]. Blood,2013,121(3):537-545. doi:10.1182/blood-2012-04-425512. 被引量:1

共引文献420

同被引文献38

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部